Sector Chart Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.860 USD | -46.74% |
|
-49.02% | -53.50% |
| 07-31 | Myriad Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Myriad Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 274M | - | - | - | ||
| 21.74B | - | ||||
| 9.36B | |||||
| 6.49B | |||||
| 6B | - | ||||
| 5.57B |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
